Ajax Therapeutics

Ajax Therapeutics is owned by Ajax Health.

View the org chart displaying its 9 main executives

Most searched biographies at Ajax Therapeutics

• Martin Vogelbaum, Interim Chief Executive Officer
• Ramy Farid, Director
• Ross Levine, Director

Create your alert
to follow the executive moves at Ajax Therapeutics.

Ajax Health has 2,293 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Ajax Therapeutics

Social media about Ajax Therapeutics

• Ajax Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ajax Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Martin Vogelbaum

Call Ajax Therapeutics at +1 914...

View the org chart

Register to receive your alert

Report an error